NM_002334.4:c.5054G>A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002334.4(LRP4):c.5054G>A(p.Arg1685Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000057 in 1,613,954 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1685L) has been classified as Uncertain significance.
Frequency
Consequence
NM_002334.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002334.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LRP4 | NM_002334.4 | MANE Select | c.5054G>A | p.Arg1685Gln | missense | Exon 34 of 38 | NP_002325.2 | ||
| LRP4-AS1 | NR_038909.1 | n.198-5062C>T | intron | N/A |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LRP4 | ENST00000378623.6 | TSL:1 MANE Select | c.5054G>A | p.Arg1685Gln | missense | Exon 34 of 38 | ENSP00000367888.1 | ||
| LRP4-AS1 | ENST00000502049.4 | TSL:2 | n.197-5062C>T | intron | N/A | ||||
| LRP4-AS1 | ENST00000531719.5 | TSL:4 | n.292-5062C>T | intron | N/A |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152082Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000438 AC: 11AN: 251400 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.0000561 AC: 82AN: 1461872Hom.: 0 Cov.: 32 AF XY: 0.0000550 AC XY: 40AN XY: 727236 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000658 AC: 10AN: 152082Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74286 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
Inborn genetic diseases Uncertain:1
The c.5054G>A (p.R1685Q) alteration is located in exon 34 (coding exon 34) of the LRP4 gene. This alteration results from a G to A substitution at nucleotide position 5054, causing the arginine (R) at amino acid position 1685 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Cenani-Lenz syndactyly syndrome Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Cenani-Lenz syndactyly syndrome;C3280402:Sclerosteosis 2;C4225377:Congenital myasthenic syndrome 17 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1685 of the LRP4 protein (p.Arg1685Gln). This variant is present in population databases (rs138238230, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with LRP4-related conditions. ClinVar contains an entry for this variant (Variation ID: 467792). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LRP4 protein function with a negative predictive value of 80%. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at